NIM
IDXX icon

NuWave Investment Management’s Idexx Laboratories IDXX Stock Holding History

NuWave Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$172K Sell
529
-1,413
-73% -$519K 0.2% 171
2022
Q2 		$681K Buy
+1,942
New +$792K 0.91% 34
2021
Q2 		– Sell
-1,108
Closed -$542K – 369
2021
Q1 		$542K Buy
+1,108
New +$555K 0.68% 40
2020
Q4 		– Sell
-3
Closed -$1K – 422
2020
Q3 		$1K Buy
+3
New +$1.11K ﹤0.01% 477

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

NuWave Investment Management's IDXX Position: Q3 2022 in Review

NuWave Investment Management reduced its Idexx Laboratories (IDXX) stake by 73% in Q3 2022, selling an estimated $519K and leaving 529 shares worth $172K. The position accounts for 0.2% of the portfolio, ranked #171.

NuWave Investment Management first reported a position in IDXX in Q3 2020 and has held it in 4 quarters since. The position peaked at $681K in Q2 2022. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • NuWave Investment Management held 529 shares of Idexx Laboratories worth $172K as of Q3 2022.
  • NuWave Investment Management sold 1,413 Idexx Laboratories shares in Q3 2022, an estimated $519K.
  • Idexx Laboratories made up 0.2% of NuWave Investment Management's portfolio in Q3 2022, its #171 holding.
  • NuWave Investment Management first reported a position in Idexx Laboratories in Q3 2020 and has held it in 4 quarters since.
  • NuWave Investment Management's Idexx Laboratories position peaked at $681K in Q2 2022.
  • 925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.